Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Donald Trump message.
View:
Post by deeppocket83 on Dec 07, 2016 10:50am

Donald Trump message.

Is a little late for Valeant. Valeant is one of the few pharmas that prepared themselves from pricing pressure by creating the pricing committee and only raising pricing in the single digits. All this has been priced into Valeant long ago when Hillary was posting about pricing since last year November.
Comment by deeppocket83 on Dec 07, 2016 6:41pm
Whoever sold today took the trump bait at face value. Only way to achieve price reductions on popular drugs can be made by loosening the regulations on drugs in the USA. Trump will have to issue large tax rebates to sustain a level playing field. Reduction in taxes and loosening the regulations will push Pharma back to their highs and consumers will get their price breaks on prescription drugs ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities